Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company is headquartered in Agoura Hills, California. Show more

4149 LIBERTY CANYON ROAD, AGOURA HILLS, CA, UNITED STATES, 91301, Agoura Hills, CA, 91301, USA

BIOTECHNOLOGY
HEALTHCARE

Market Cap

229.2M

52 Wk Range

$0.00 - $0.00

Previous Close

$2.27

Open

$2.27

Volume

N/A

Day Range

$2.27 - $2.27

Enterprise Value

-174.4M

Cash

58.27M

Avg Qtr Burn

-38.96M

Insider Ownership

7.15%

Institutional Own.

91.98%

Qtr Updated

03/31/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Lonigutamab Details
Thyroid Eye Disease , Eye disease

Phase 3

Initiation

Izokibep Details
Axial spondyloarthritis

Failed

Discontinued

Izokibep Details
Psoriatic arthritis

Failed

Discontinued

SLRN-517 Details
Allergy, Inflammatory disease, KIT/Mast cell diseases

Failed

Discontinued

Izokibep Details
Hidradenitis suppurativa

Failed

Discontinued

Izokibep Details
Uveitis , Eye disease

Failed

Discontinued